News Chart Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 21:00:00 02/07/2026 BST			5-day change	1st Jan Change
3.630 ^USD	+4.91%		+19.41%	+32.00%

06-03	Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort	MT
06-03	Perspective Therapeutics Doses First Patient with [212Pb]Vmt-?-Net in Meningioma Cohort of Phase 1/2A Study	CI

5ea.QkVhAon-rk2H_VJubomQF_o_gnp-ekkQLt4-7rzrZCA.KCAJNOSG_DrXyyEPPfPddpl80DgSOwJEWppEhNqaHUErBAM3_4b0K8CoCw~0173067d71c8fa0fdaf56adefd67c254